An adenovirus vector with a chimeric fiber derived from canine adenovirus type 2 displays novel tropism

被引:55
作者
Glasgow, JN
Kremer, EJ
Hemminki, A
Siegal, GP
Douglas, JT
Curiel, DT
机构
[1] Univ Alabama, Birmingham Gene Therapy Ctr, Dept Med, Div Human Gene Therapy, Birmingham, AL 35294 USA
[2] Univ Alabama, Birmingham Gene Therapy Ctr, Dept Pathol, Div Human Gene Therapy, Birmingham, AL 35294 USA
[3] Univ Alabama, Birmingham Gene Therapy Ctr, Dept Surg, Div Human Gene Therapy, Birmingham, AL 35294 USA
[4] CNRS, UMR 5535, IFR 122, Inst Genet Mol Montpellier, F-34293 Montpellier, France
[5] Univ Alabama, Gene Therapy Ctr, Birmingham, AL 35294 USA
[6] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA
[7] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA
[8] Univ Alabama, Dept Surg, Birmingham, AL 35294 USA
关键词
gene therapy; adenovirus; targeting; tropism modification; coxsackie and adenovirus receptor (CAR);
D O I
10.1016/j.virol.2004.03.028
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Many clinically relevant tissues are refractory to Ad5 transduction because of negligible levels of the primary Ad5 receptor, the coxsackie and adenovirus receptor (CAR). Thus, development of Ad vectors that display CAR-independent tropism could lead directly to therapeutic gain. The Toronto strain of canine adenovirus type 2 (CAV2) exhibits native tropism that is augmented by, but not fully dependent upon, CAR for cellular transduction. We hypothesized that an Ad5 vector containing the nonhuman CAV2 knob would provide expanded tropism and constructed Ad5Luc1-CK, an E1-deleted Ad5 vector encoding the fiber knob domain from CAV2. Ad5Luc1-CK gene delivery to CAR-deficient cells was augmented up to 30-fold versus the Ad5 control vector, and correlated with increased cell surface binding. Further, we confirmed the importance of cellular integrins to Ad5Luc1-CK transduction. Herein, we present the rationale, design, purification, and characterization of a novel tropism modified, infectivity-enhanced Ad vector. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:103 / 116
页数:14
相关论文
共 63 条
[31]  
Kelly FJ, 2000, CLIN CANCER RES, V6, P4323
[32]   The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells [J].
Kim, M ;
Sumerell, LA ;
Belousova, N ;
Lyons, GR ;
Carey, DE ;
Krasnykh, V ;
Douglas, JT .
BRITISH JOURNAL OF CANCER, 2003, 88 (09) :1411-1416
[33]   The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells [J].
Kim, M ;
Zinn, KR ;
Barnett, BG ;
Sumerel, LA ;
Krasnykh, V ;
Curiel, DT ;
Douglas, JT .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (14) :1917-1926
[34]  
Koptopoulos G., 1981, Veterinary Bulletin, V51, P135
[35]   Characterization of an adenovirus vector containing heterologous peptide epitope in the HI loop of the fiber knob [J].
Krasnykh, V ;
Dmitriev, I ;
Mikheeva, G ;
Miller, CR ;
Belousova, N ;
Curiel, DT .
JOURNAL OF VIROLOGY, 1998, 72 (03) :1844-1852
[36]   Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin [J].
Krasnykh, V ;
Belousova, N ;
Korokhov, N ;
Mikheeva, G ;
Curiel, DT .
JOURNAL OF VIROLOGY, 2001, 75 (09) :4176-4183
[37]   Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism [J].
Krasnykh, VN ;
Mikheeva, GV ;
Douglas, JT ;
Curiel, DT .
JOURNAL OF VIROLOGY, 1996, 70 (10) :6839-6846
[38]   Canine adenovirus vectors: an alternative for adenovirus mediated gene transfer [J].
Kremer, EJ ;
Boutin, S ;
Chillon, M ;
Danos, O .
JOURNAL OF VIROLOGY, 2000, 74 (01) :505-512
[39]   Biology of ovine adenovirus infection of nonpermissive cells [J].
Kümin, D ;
Hofmann, C ;
Rudolph, M ;
Both, GW ;
Löser, P .
JOURNAL OF VIROLOGY, 2002, 76 (21) :10882-10893
[40]   Ovine adenovirus vectors mediate efficient gene transfer to skeletal muscle [J].
Löser, P ;
Hillgenberg, M ;
Arnold, W ;
Both, GW ;
Hofmann, C .
GENE THERAPY, 2000, 7 (17) :1491-1498